Ischemia–reperfusion injury after spinal cord decompressive surgery—An in vivo rat model

Abstract

Background: Although decompression surgery is the optimal treatment for patients with severe degenerative cervical myelopathy (DCM), some individuals experience no improvement or even a decline in neurological function after surgery, with spinal cord ischemia–reperfusion injury (SCII) identified as the primary cause. Spinal cord compression results in local ischemia and blood perfusion following decompression is fundamental to SCII. However, owing to inadequate perioperative blood flow monitoring, direct evidence regarding the occurrence of SCII after decompression is lacking. The objective of this study was to establish a suitable animal model for investigating the underlying mechanism of spinal cord ischemia–reperfusion injury following decompression surgery for degenerative cervical myelopathy (DCM) and to elucidate alterations in neurological function and local blood flow within the spinal cord before and after decompression.

Methods: Twenty-four Sprague–Dawley rats were allocated to three groups: the DCM group (cervical compression group, with implanted compression material in the spinal canal, n = 8), the DCM-D group (cervical decompression group, with removal of compression material from the spinal canal 4 weeks after implantation, n = 8), and the SHAM group (sham operation, n = 8). Von Frey test, forepaw grip strength, and gait were assessed within 4 weeks post-implantation. Spinal cord compression was evaluated using magnetic resonance imaging. Local blood flow in the spinal cord was monitored during the perioperative decompression. The rats were sacrificed 1 week after decompression to observe morphological changes in the compressed or decompressed segments of the spinal cord. Additionally, NeuN expression and the oxidative damage marker 8-oxoG DNA were analyzed.

Results: Following spinal cord compression, abnormal mechanical pain worsened, and a decrease in forepaw grip strength was observed within 1–4 weeks. Upon decompression, the abnormal mechanical pain subsided, and forepaw grip strength was restored; however, neither reached the level of the sham operation group. Decompression leads to an increase in the local blood flow, indicating improved perfusion of the spinal cord. The number of NeuN-positive cells in the spinal cord of rats in the DCM-D group exceeded that in the DCM group but remained lower than that in the SHAM group. Notably, a higher level of 8-oxoG DNA expression was observed, suggesting oxidative stress following spinal cord decompression.

Conclusion: This model is deemed suitable for analyzing the underlying mechanism of SCII following decompressive cervical laminectomy, as we posit that the obtained results are comparable to the clinical progression of degenerative cervical myelopathy (DCM) post-decompression and exhibit analogous neurological alterations. Notably, this model revealed ischemic reperfusion in the spinal cord after decompression, concomitant with oxidative damage, which plausibly underlies the neurological deterioration observed after decompression.

Keywords

8-oxoG DNA / degenerative cervical myelopathy / spinal cord ischemia–reperfusion injury / surgical decompression

References

[1] Badhiwala JH, Ahuja CS, Akbar MA, et al. Degenerative cervical myelopathy—update and future directions. Nat Rev Neurol. 2020; 16(2): 108-124.

[2] Nouri A, Tetreault L, Singh A, Karadimas SK, Fehlings MG. Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis. Spine. 2015; 40(12): E675-E693.

[3] Bakhsheshian J, Mehta VA, Liu JC. Current diagnosis and management of cervical spondylotic myelopathy. Global Spine J. 2017; 7(6): 572-586.

[4] Sugawara T. Neurologic complications in managing degenerative cervical myelopathy: pathogenesis, prevention, and management. Neurosurg Clin N Am. 2018; 29(1): 129-137.

[5] Halvorsen CM, Lied B, Harr ME, et al. Surgical mortality and complications leading to reoperation in 318 consecutive posterior decompressions for cervical spondylotic myelopathy. Acta Neurol Scand. 2011; 123: 358-365.

[6] LeMaire SA, Price MD, Green SY, Zarda S, Coselli JS. Results of open thoracoabdominal aortic aneurysm repair. Ann Cardiothor Surg. 2012; 1(3): 286-292.

[7] Laliberte AM, Karadimas SK, Vidal PM, Satkunendrarajah K, Fehlings MG. Mir21 modulates inflammation and sensorimotor deficits in cervical myelopathy: data from humans and animal models. Brian Commun. 2021; 3(1): fcaa234.

[8] Karadimas SK, Moon ES, Yu W-R, et al. A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research. Neurobiol Dis. 2013; 54: 43-58.

[9] Vidal PM, Karadimas SK, Ulndreaj A, et al. Delayed decompression exacerbates ischemia-reperfusion injury in cervical compressive myelopathy. JCI Insight. 2017; 2(11): e92512.

[10] Karadimas SK, Laliberte AM, Tetreault L, et al. Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy. Sci Transl Med. 2015; 7(316): 316ra194.

[11] Miyagi M, Millecamps M, Danco AT, Ohtori S, Takahashi K, Stone LS. ISSLS prize winner: increased innervation and sensory nervous system plasticity in a mouse model of low back pain due to intervertebral disc degeneration. Spine. 2014; 39(17): 1345-1354.

[12] Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol. 1995; 132(2): 220-228.

[13] Ratcliffe JF. The arterial anatomy of the adult human lumbar vertebral body: a microarteriographic study. J Anat. 1980; 131(pt 1): 57-79.

[14] Lebret A, Lévy S, Pfender N, et al. Investigation of perfusion impairment in degenerative cervical myelopathy beyond the site of cord compression. Sci Rep. 2023; 13(1): 22660.

[15] Vidal PM, Ulndreaj A, Badner A, Hong J, Fehlings MG. Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system. J Neuroinflammation. 2018; 15(1): 222.

[16] Hubertus V, Meyer L, Roolfs L, et al. In vivo imaging in experimental spinal cord injury—techniques and trends. Brain Spine. 2021; 2: 100859.

[17] Nishida N, Kato Y, Imajo Y, Kawano S, Taguchi T. Biomechanical analysis of cervical spondylotic myelopathy: the influence of dynamic factors and morphometry of the spinal cord. J Spinal Cord Med. 2012; 35(4): 256-261.

[18] Chung W-H, Lee J-H, Chung D-J, et al. Improved rat spinal cord injury model using spinal cord compression by percutaneous method. J Vet Sci. 2013; 14(3): 329-335.

[19] Wang J, Rong W, Hu X, et al. Hyaluronan tetrasaccharide in the cerebrospinal fluid is associated with self-repair of rats after chronic spinal cord compression. Neuroscience. 2012; 210: 467-480.

[20] Yao M, Li G, Zhou L-y, et al. Shikonin inhibits neuronal apoptosis via regulating endoplasmic reticulum stress in the rat model of double-level chronic cervical cord compression. Cell Biol Toxicol. 2023; 39(3): 907-928.

[21] Yang T et al. Inflammation level after decompression surgery for a rat model of chronic severe spinal cord compression and effects on ischemia-reperfusion injury. Neurol Med Chir. 2015; 55(7): 578-586.

[22] Hu Y, Wen C-Y, Li T-H, Cheung MM-H, Wu E X-k, Luk KD-K. Somatosensory-evoked potentials as an indicator for the extent of ultrastructural damage of the spinal cord after chronic compressive injuries in a rat model. Clin Neurophysiol. 2011; 122(7): 1440-1447.

[23] Tu J, Vargas Castillo J, das A, Diwan AD. Degenerative cervical myelopathy: insights into its pathobiology and molecular mechanisms. J Clin Med. 2021; 10(6): 1214.

[24] Lee-Kubli CA, Ingves M, Henry KW, et al. Analysis of the behavioral, cellular and molecular characteristics of pain in severe rodent spinal cord injury. Exp Neurol. 2016; 278: 91-104.

[25] Haddas R, Ju KL. Gait alteration in cervical Spondylotic myelopathy elucidated by ground reaction forces. Spine. 2019; 44(1): 25-31.

[26] Haddas R, Patel S, Arakal R, Boah A, Belanger T, Ju KL. Spine and lower extremity kinematics during gait in patients with cervical spondylotic myelopathy. Spine J. 2018; 18(9): 1645-1652.

[27] Haddas R, Lieberman I, Arakal R, Boah A, Belanger T, Ju K. Effect of cervical decompression surgery on gait in adult cervical spondylotic myelopathy patients. Clin Spine Surg. 2018; 31(10): 435-440.

[28] Paul AJ, Amritanand R, Margabandhu P, Karuppusami R, David KS, Krishnan V. Composite grip strength as a marker of outcome in patients surgically treated for degenerative cervical myelopathy. Asian Spine J. 2021; 15(5): 664-672.

[29] Kobayashi H, Otani K, Nikaido T, et al. Grip strength as a screening index for severe degenerative cervical myelopathy in primary care: development of cutoff values using receiver operating curve analysis. Int J General Med. 2021; 14: 9863-9872.

[30] McGrath R, Tomkinson GR, Clark BC, et al. Assessing additional characteristics of muscle function with digital handgrip dynamometry and Accelerometry: framework for a novel handgrip strength protocol. J Am Med Dir Assoc. 2021; 22(11): 2313-2318.

[31] Lin K-H, Ying-Chen C, Luh J-J, Wang C-H, Chang Y-J. H-reflex, muscle voluntary activation level, and fatigue index of flexor carpi radialis in individuals with incomplete cervical cord injury. Neurorehabil Neural Repair. 2012; 26(1): 68-75.

[32] Dhillon RS, Parker J, Syed YA, et al. Axonal plasticity underpins the functional recovery following surgical decompression in a rat model of cervical spondylotic myelopathy. Acta Neuropathol Commun. 2016; 4: 1889.

[33] Lin R, Roseborough G, Dong Y, Williams GM, Wei C. DNA damage and repair system in spinal cord ischemia. J Vasc Surg. 2003; 37(4): 847-858.

[34] Qiu Y, Liu B, Zhou W, et al. Repair-driven DNA tetrahedral nanomachine combined with DNAzyme for 8-oxo guanine DNA glycosylase activity assay, drug screening and intracellular imaging. Analyst. 2023; 149(2): 537-545.

[35] Azzouz D, Palaniyar N. Mitochondrial ROS and base excision repair steps leading to DNA nick formation drive ultraviolet induced-NETosis. Front Immunol. 2023; 14: 1198716.

[36] Wang Y, Lin J, Shu J, Li H, Ren Z. Oxidative damage and DNA damage in lungs of an ovalbumin-induced asthmatic murine model. J Thorac Dis. 2018; 10(8): 4819-4830.

[37] Nastasi C, Mannarino L, D'Incalci M. DNA damage response and immune defense. Int J Mol Sci. 2020; 21(20): 7504.

[38] Pateras IS, Havaki S, Nikitopoulou X, et al. The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where. Pharmacol Ther. 2015; 154: 36-56.

[39] Souliotis VL, Vlachogiannis NI, Pappa M, Argyriou A, Ntouros PA, Sfikakis PP. DNA damage response and oxidative stress in systemic autoimmunity. Int J Mol Sci. 2019; 21(1): 55.

[40] Theofilopoulos AN, Kono DH, Baccala R. The multiple pathways to autoimmunity. Nat Immunol. 2017; 18(7): 716-724.

[41] Wang Z, Tan Y, Xu F. Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model. Tissue Cell. 2023; 81: 102024.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.